185 related articles for article (PubMed ID: 12534361)
1. Immunohistochemical detection of cell cycle regulators, Fhit protein and apoptotic cells in parathyroid lesions.
Thomopoulou GE; Tseleni-Balafouta S; Lazaris AC; Koutselini H; Kavantzas N; Davaris PS
Eur J Endocrinol; 2003 Jan; 148(1):81-7. PubMed ID: 12534361
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical investigation of angiogenic factors in parathyroid proliferative lesions.
Lazaris AC; Tseleni-Balafouta S; Papathomas T; Brousalis T; Thomopoulou G; Agrogiannis G; Patsouris ES
Eur J Endocrinol; 2006 Jun; 154(6):827-33. PubMed ID: 16728542
[TBL] [Abstract][Full Text] [Related]
3. Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity.
Loda M; Lipman J; Cukor B; Bur M; Kwan P; DeLellis RA
Hum Pathol; 1994 Oct; 25(10):1050-6. PubMed ID: 7927309
[TBL] [Abstract][Full Text] [Related]
4. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.
Yamaguchi S; Yachiku S; Morikawa M
J Clin Endocrinol Metab; 1997 Aug; 82(8):2681-8. PubMed ID: 9253354
[TBL] [Abstract][Full Text] [Related]
5. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
Tominaga Y; Tsuzuki T; Uchida K; Haba T; Otsuka S; Ichimori T; Yamada K; Numano M; Tanaka Y; Takagi H
Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric DNA analysis of benign hyperfunctioning parathyroid glands: significant difference in the S phase fraction and proliferative index between adenomas and hyperplasias.
Berczi C; Bocsi J; Balázs G; Lukács G
Pathology; 2002 Oct; 34(5):442-5. PubMed ID: 12408343
[TBL] [Abstract][Full Text] [Related]
7. [The use of flow cytometry in the study of parathyroid hyperplasia and adenomas].
Mangili F; Sassi I; Schiaffino E; Zogno C; Cantaboni A; Schmid C
Pathologica; 1992; 84(1092):459-65. PubMed ID: 1491887
[TBL] [Abstract][Full Text] [Related]
8. Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas.
Yano S; Sugimoto T; Tsukamoto T; Chihara K; Kobayashi A; Kitazawa S; Maeda S; Kitazawa R
Eur J Endocrinol; 2003 Apr; 148(4):403-11. PubMed ID: 12656660
[TBL] [Abstract][Full Text] [Related]
9. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.
Vasef MA; Brynes RK; Sturm M; Bromley C; Robinson RA
Mod Pathol; 1999 Apr; 12(4):412-6. PubMed ID: 10229506
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism.
Szende B; Farid P; Végso G; Perner F; Kopper L
Pathol Oncol Res; 2004; 10(2):98-103. PubMed ID: 15188026
[TBL] [Abstract][Full Text] [Related]
12. Morphological evaluation of parathyroid adenomas and immunohistochemical analysis of PCNA and Ki-67 proliferation markers.
Demıralay E; Altaca G; Demırhan B
Turk Patoloji Derg; 2011; 27(3):215-20. PubMed ID: 21935871
[TBL] [Abstract][Full Text] [Related]
13. Assessment of proliferative activity of glandular cells in hyperfunctioning parathyroid gland using flow cytometric and immunohistochemical methods.
Xiao-Lin P; Koide N; Kobayashi S; Kobayashi M; Sugenoya A; Iida F; Katsuyama T; Usuda N; Nagata T
World J Surg; 1996; 20(3):361-6; discussion 367. PubMed ID: 8661846
[TBL] [Abstract][Full Text] [Related]
14. Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining.
Abbona GC; Papotti M; Gasparri G; Bussolati G
Hum Pathol; 1995 Feb; 26(2):135-8. PubMed ID: 7860042
[TBL] [Abstract][Full Text] [Related]
15. [Nuclear DNA content of parathyroid tumor with hyperparathyroidism].
Suzuki S; Ando Y; Ami H; Furukawa H; Tsuchiya A; Abe R
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():486-91. PubMed ID: 9589058
[TBL] [Abstract][Full Text] [Related]
16. The role of hyperplasia in multiple parathyroid adenomas.
Larian B; Alavi S; Roesler J; Namazie A; Blackwell K; Calcaterra TC; Wang MB
Head Neck; 2001 Feb; 23(2):134-9. PubMed ID: 11303630
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor status in hyperparathyroidism: immunocytochemical and In situ hybridization study.
Sadler GP; Morgan JM; Jasani B; Douglas-Jones A; Wheeler MH
World J Surg; 1996 Sep; 20(7):736-42; discussion 742-3. PubMed ID: 8678944
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein.
Erickson LA; Jin L; Wollan P; Thompson GB; van Heerden JA; Lloyd RV
Am J Surg Pathol; 1999 Mar; 23(3):288-95. PubMed ID: 10078919
[TBL] [Abstract][Full Text] [Related]
19. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of the int-2 gene product in primary and secondary parathyroid lesions.
Tseleni-Balafouta S; Thomopoulou G; Lazaris ACh; Koutselini H; Davaris PS
Eur J Endocrinol; 2002 Jan; 146(1):57-60. PubMed ID: 11751068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]